Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study
详细信息    查看全文
  • 作者:Anna Teresa Mazzeo (1) (2)
    óscar Luís Alves (3)
    Charlotte B. Gilman (2)
    Ronald L. Hayes (4) (5)
    Christos Tolias (6)
    K. Niki Kunene (7)
    M. Ross Bullock (8)
  • 关键词:Cyclosporin A ; Neuroprotection ; Traumatic brain injury ; Cerebral microdialysis ; Cerebral hemodynamics
  • 刊名:Acta Neurochirurgica
  • 出版年:2008
  • 出版时间:October 2008
  • 年:2008
  • 卷:150
  • 期:10
  • 页码:1019-1031
  • 全文大小:518KB
  • 参考文献:1. Albensi BC, Sullivan PG, Thompson MB, Scheff SW, Mattson MP (2000) Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity. Exp Neurol 162:385-89 CrossRef
    2. Alessandri B, Rice AC, Levasseur J, DeFord M, Hamm RJ, Bullock MR (2002) Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats. J Neurotrauma 19:829-41 CrossRef
    3. Alves OL, Doyle AJ, Clausen T, Gilman C, Bullock R (2003) Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis. Ann N Y Acad Sci 993:25-4
    4. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-73 CrossRef
    5. Benveniste H (1989) Brain microdialysis. J Neurochem 52:1667-679 CrossRef
    6. Brain Trauma Foundation Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS (2007) Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma 24:S59–S64
    7. Buki A, Okonkwo DO, Povlishock JT (1999) Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J Neurotrauma 16:511-21
    8. Bullock R, Zauner A, Woodward JJ, Myseros J, Choi SC, Ward JD, Marmarou A, Young HF (1998) Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 89:507-18
    9. Bullock MR, Lyeth BG, Muizelaar JP (1999) Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 45:207-17 CrossRef
    10. Cesarini KG, Enblad P, Ronne-Engstrom E, Marklund N, Salci K, Nilsson P, Hardemark HG, Hillered L, Persson L (2002) Early cerebral hyperglycolysis after subarachnoid haemorrhage correlates with favourable outcome. Acta Neurochir 144:1121-131 CrossRef
    11. Chaurasia CS (1999) In vivo microdialysis sampling: theory and applications. Biomed Chromatogr 13:317-32 CrossRef
    12. Christians U, Gottschalk S, Miljus J, Hainz C, Benet LZ, Leibfritz D, Serkova N (2004) Alterations in glucose metabolism by cyclosporin in rat brain slices link to oxidative stress: interactions with mTOR inhibitors. Br J Pharmacol 143:388-96 CrossRef
    13. Danovitch GM (2005) Immunosuppressive medications and protocols for kidney transplantation. In: Danovitch GM (ed) Handbook of kidney transplantation. Lippincott Williams & Wilkins, Philadelphia, pp 72-34
    14. Domanska-Janik K, Buzanska L, Dluzniewska J, Kozlowska H, Sarnowska A, Zablocka B (2004) Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome c to cytoplasm. Mol Brain Res 121:50-9 CrossRef
    15. Dusik JR, Glenn TC, Lee WN, Vespa PM, Kelly DF, Lee SM, Hovda DA, Martin NA (2007) Increased pentose phosphate pathway flux after clinical traumatic brain injury: a [1,2-13C2] glucose labeling study in humans. J Cereb Blood Flow Metab 27:1593-02 CrossRef
    16. Enblad P, Valtysson J, Andersson J, Lilja A, Valind S, Antoni G, Langstrom B, Hillered L, Persson L (1996) Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab 16:637-44 CrossRef
    17. Enblad P, Frykholm P, Valtysson J, Silander HC, Andersson J, Fasth KJ, Watanabe Y, Langstrom B, Hillered L, Persson L (2001) Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke 32:1574-580
    18. Fiskum G (2000) Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17:843-55 CrossRef
    19. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T (1998) Cyclosporin A, but not FK506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 18:5151-159
    20. Gardiner SM, March JE, Kemp PA, Fallgren B, Bennett T (2004)) Regional haemodynamic effects of cyclosporin A, tacrolimus and sirolimus in rats. Br J Pharmacol 141:634-43 CrossRef
    21. Goodman JC, Valadka AB, Gopinath SP, Uzura M, Robertson CS (1999) Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med 27:1965-973 CrossRef
    22. Gunter TE, Gunter KK, Sheu SS, Gavin CE (1994) Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol 267:C313–C339
    23. Katsura K, Ekholm A, Siesjo BK (1992) Tissue PCO2 in brain ischemia related to lactate content in normo- and hypercapnic rats. J Cereb Blood Flow Metab 12:270-80
    24. Kett-White R, Hutchinson PJ, Al-Rawi PG, Gupta AK, Pickard JD, Kierkpatrick PJ (2002) Adverse cerebral events detected after subarachnoid hemorrhage using brain oxygen and microdialysis probes. Neurosurgery 50:1213-222 CrossRef
    25. Kosch M, Hausberg M, Suwelack B (2003) Studies on effects of calcineurin inhibitor withdrawal on arterial distensibility and endothelial function in renal transplant recipients. Transplantation 76:1516-519 CrossRef
    26. Koura SS, Doppenberg EM, Marmarou A, Choi S, Young HF, Bullock R (1998) Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl 71:244-46
    27. Hlatky R, Valadka AB, Goodman JC, Contant CF, Robertson CS (2004) Patterns of energy substrates during ischemia measured in the brain by microdialysis. J Neurotrauma 21:894-06 CrossRef
    28. Hillered L, Persson L, Ponten U, Ungerstedt U (1990) Neurometabolic monitoring of the ischaemic human brain using microdialysis. Acta Neurochir (Wien) 102:91-7 CrossRef
    29. Hillered L, Vespa PM, Hovda DA (2005) Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 22:3-1 CrossRef
    30. Hillered L, Persson L, Nilsson P, Ronne-Engstrom E, Enblad P (2006) Continuous monitoring of cerebral metabolism in traumatic brain injury: a focus on cerebral microdialysis. Curr Opin Crit Care 12:112-18 CrossRef
    31. Hutchinson PJ, Gupta AK, Fryer TF, Al-Rawi PG, Chatfield DA, Coles JP, O’Connell MT, Kett-White R, Minhas PS, Aigbirhio FI, Clark JC, Kirkpatrikck PJ, Menon DK, Pickard JD (2002) Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: a combined microdialysis and triple oxygen positron emission tomography study. J Cereb Blood Flow Metab 22:735-45 CrossRef
    32. Johnston AJ, Steiner LA, Coles JP, Chatfield DA, Fryer TD, Smielewski P, Hutchinson PJ, O’Connell MT, Al-Rawi PG, Aigbirihio FI, Clark JC, Pickard JD, Gupta AK, Menon DK (2005) Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury. Crit Care Med 33:189-95 CrossRef
    33. Langemann H, Mendelowitsch A, Landolt H, Alessandri B, Gratzl O (1995) Experimental and clinical monitoring of glucose by microdialysis. Clin Neurol Neurosurg 97:149-55 CrossRef
    34. Langemann H, Alessandri B, Mendelowitsch A, Feuerstein T, Landolt H, Gratzl O (2001) Extracellular levels of glucose and lactate measured by quantitative microdialysis in the human brain. Neurol Res 23:531-36 CrossRef
    35. Li PA, Uchino H, Elmer E, Siesjo BK (1997) Amelioration by cyclosporin A of brain damage following 5 or 10?min of ischemia in rats subjected to preischemic hyperglycemia. Brain Res 753:133-40 CrossRef
    36. Lifshitz J, Sullivan PG, Hovda DA, Wieloch T, Mcintosh TK (2004) Mitochondrial damage and dysfunction in traumatic brain injury. Mitochondrion 4:705-13 CrossRef
    37. Lungu AO, Jin ZG, Yamawaki H, Tanimoto T, Wong C, Berk B (2004) Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae. J Biol Chem 279:48794-8800 CrossRef
    38. Marklund N, Salci K, Lewen A, Hillered L (1997) Glycerol as a marker for post-traumatic membrane phospholipid degradation in rat brain. Neuroreport 8:1457-461 CrossRef
    39. Marrif H, Juurlink BH (1999) Astrocytes respond to hypoxia by increasing glycolytic capacity. J Neurosci Res 57:255-60 CrossRef
    40. Matsumoto S, Friberg H, Ferrand-Drake M, Wieloch T (1999) Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 19:736-41 CrossRef
    41. Mazzeo AT, Kunene N, Gilman C, Hamm R, Bullock R (2006) Severe human traumatic brain injury, but not cyclosporin A treatment, depresses activated T lymphocytes early after injury. J Neurotrauma 23:962-75 CrossRef
    42. Menzel M, Doppenberg EM, Zauner A, Soukup J, Reinert MM, Bullock R (1999) Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. J Neurosurg 91:1-0
    43. Meyerson BA, Linderoth B, Karlsson H, Ungerstedt U (1990) Microdialysis in the human brain: extracellular measurements in the thalamus of parkinsonian patients. Life Sci 46:301-08 CrossRef
    44. Nishiyama A, Kobori H, Fukui T, Zhang GX, Yao L, Rahman M, Hitomi H, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y (2003) Role of angiotensin II and reactive oxygen species in cyclosporin A-dependent hypertension. Hypertension 42:754-60 CrossRef
    45. Okonkwo DO, Povlishock JT (1999) An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab 19:443-51 CrossRef
    46. Okonkwo DO, Buki A, Siman R, Povlishock JT (1999) Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 10:353-58 CrossRef
    47. Okonkwo DO, Melon DE, Pellicane AJ, Mutlu LK, Rubin DG, Stone JR, Helm GA (2003) Dose–response of cyclosporin A in attenuating traumatic axonal injury in rat. NeuroReport 14:463-66 CrossRef
    48. Peerdeman SM, Girbes ARJ, Polderman KH, Vandertop WP (2003) Changes in cerebral interstitial glycerol concentration in head-injured patients; correlation with secondary events. Intensive Care Med 29:1825-828 CrossRef
    49. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimultes aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91:10625-0629 CrossRef
    50. Persson L, Valtysson J, Enblad P, Warme PE, Cesarini K, Lewen A, Hillered L (1996) Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg 84:606-16
    51. Pettus EH, Povlishock JT (1996) Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res 722:1-1 CrossRef
    52. Povlishock JT, Pettus EH (1996) Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. Acta Neurochir Suppl 66:81-6
    53. Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, Nordstrom C-H (2000) Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 47:701-09 CrossRef
    54. Robertson CS (2001) Management of cerebral perfusion pressure after traumatic brain injury. Anesthesiology 95:1513-517 CrossRef
    55. Roullet JB, Xue H, McCarron DA, Holcomb S, Bennett WM (1994) Vascular mechanism of cyclosporin-induced hypertension in the rat. J Clin Invest 93:2244-250 CrossRef
    56. Sanchez-Lozada LG, Gamba G, Bolio A, Jimenez F, Herrera-Acosta J, Bobadilla NA (2000) Nifedipine prevents changes in nitric oxide synthase mRNA levels induced by cycloporine. Hypertension 36:642-47
    57. Scheff SW, Sullivan PG (1999) Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J Neurotrauma 16:783-92
    58. Schneweis S, Grond M, Staub F, Brinker G, Neveling M, Dohmen C, Graf R, Heiss WD (2001) Predictive value of neurochemical monitoring in large middle cerebral artery infarction. Stroke 32:1863-867
    59. Schulz MK, Wang LP, Tange M, Bjerre P (2000) Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 93:808-14
    60. Shaltout HA, Abdel-Rahman AA (2003) Cyclosporin induces progressive attenuation of baroreceptor heart rate response and cumulative pressor response in conscious unrestrained rats. J Pharmacol Exp Ther 305:966-73 CrossRef
    61. Shiga Y, Onodera H, Matsuo Y, Kogure K (1992) Cyclosporin A protects against ischemia–reperfusion injury in the brain. Brain Res 595:145-48 CrossRef
    62. Signoretti S, Marmarou A, Tavazzi B, Dunbar J, Amorini AM, Lazzarino G, Vagnozzi R (2004) The protective effect of Cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. J Neurotrauma 21:1154-167
    63. Skjoth-Rasmussen J, Schultz M, Kristensen SR, Bjerre P (2004) Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurismal subarachnoid hemorrhage. J Neurosurg 100:8-5
    64. Stahl N, Mellergard P, Hallstr?m A, Ungerstedt U, Nordstrom CH (2001) Intracerebral microdialysis and bedside biochemical analysis in patients with fatal traumatic brain lesions. Acta Anaesthesiol Scand 45:977-85 CrossRef
    65. Starkov AA, Chinopoulos C, Fiskum G (2004) Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 36:257-64 CrossRef
    66. Staub F, Graf R, Gabel P, Kochling M, Klug N, Heiss WD (2000) Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage. Neurosurgery 47:1106-116 CrossRef
    67. Sullivan PG, Thompson MB, Schdeff SW (1999) Cyclosporin A attuenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 160:226-34 CrossRef
    68. Sullivan PG, Rabchevsky AG, Hicks RR, Gibson TR, Fletcher-Turner A, Scheff SW (2000) Dose–response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101:289-95 CrossRef
    69. Sullivan PG, Thompson M, Scheff SW (2000) Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp Neurol 161:631-37 CrossRef
    70. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE (2005) Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res 79:231-39 CrossRef
    71. Tolias CM, Reinert M, Seiler R, Gilman C, Scharf A, Bullock MR (2004) Normobaric hyperoxia-induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. J Neurosurg 101:435-44
    72. Uchino H, Elmer E, Uchino K, Li PA, He QP, Smith ML, Siesjo BK (1998) Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res 812:216-26 CrossRef
    73. Uchino H, Minamikawa-Tachino R, Kristian T, Perkins G, Narazaki M, Siejo BK, Shibasaki F (2002) Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis 10:219-33 CrossRef
    74. Ungerstedt U, Rostami E (2004) Microdialysis in neurointensive care. Curr Pharm Des 10:2145-152 CrossRef
    75. Valadka AB, Goodman JC, Gopinath SP, Uzura M, Robertson CS (1998) Comparison of brain tissue oxygen tension to microdialysis-based measures of cerebral ischemia in fatally head-injured patients. J Neurotrauma 15:509-19
    76. Valtysson J, Persson L, Hillered L (1998) Extracellular ischemia markers in repeated global ischaemia and secondary hypoxaemia monitored by microdialysis in rat brain. Acta Neurochir 140:387-95 CrossRef
    77. Vespa PM, McArthur D, O’Phelan K, Glenn T, Etchepare M, Kelly D, Bergsneider M, Martin NA (2003) Persistently low extracellular glucose correlates with poor outcome 6?months after human traumatic brain injury despite a lack of increased lactate: a microdialysis study. J Cereb Blood Flow Metab 23:865-77 CrossRef
    78. Vespa P, Bergsneider M, Hattori N, wu H-M, Huang S-C, Martin NA, Glenn TC, McArthur DL, Hovda DA (2005) Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 25:763-74 CrossRef
    79. Wang, X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-933
    80. Xiong Y, Gu Q, Peterson PL, Muizelaar JP, Lee CP (1997) Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma 14:23-4
    81. Yoshimoto T, Siesjo BK (1999) Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 839:283-91 CrossRef
    82. Yu G, Hess DC, Borlongan CV (2004) Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke. Brain Res 1018:32-7 CrossRef
    83. Zauner A, Bullock R (1995) The role of excitatory amino acids in severe brain trauma: opportunities for therapy: a review. J Neurotrauma 12:547-54
  • 作者单位:Anna Teresa Mazzeo (1) (2)
    óscar Luís Alves (3)
    Charlotte B. Gilman (2)
    Ronald L. Hayes (4) (5)
    Christos Tolias (6)
    K. Niki Kunene (7)
    M. Ross Bullock (8)

    1. Department of Neuroscience, Psychiatric and Anesthesiological Sciences, University of Messina, Viale Regina Margherita n. 59, 98121, Messina, Italy
    2. Division of Neurosurgery, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, USA
    3. Servi?o de Neurocirurgia, Centro Hospitalar de Vila Nova de Gaia, Faculdade de Medicina da Universitade do Porto, Porto, Portugal
    4. Department of Anesthesiology, University of Florida, Gainesville, FL, USA
    5. Center of Innovative Research, Banyan Biomarkers, Inc., Alachua, FL, USA
    6. Department of Neurosurgery, Kings College Hospital, London, UK
    7. Department of Computer Information Systems, University of Louisville, Louisville, KY, USA
    8. Department of Neurosurgery, University of Miami Miller School of Medicine, Lois Pope LIFE Center, Miami, FL, USA
文摘
Background Mitochondrial dysfunction is a major limiting factor in neuronal recovery following traumatic brain injury. Cyclosporin A (CsA) has been recently proposed for use in the early phase after severe head injury, for its ability to preserve mitochondrial bioenergetic state, potentially exerting a neuroprotective effect. The aim of this study was, therefore, to evaluate the effect of CsA on brain energy metabolism, as measured by cerebral microdialysis, and on cerebral hemodynamics, in a group of severely head injured patients. Methods Fifty adult patients with a severe head injury were enrolled in this randomized, double-blind, placebo-controlled study. Patients received 5?mg/kg of CsA over 24?h, or placebo, within 12?h of the injury. A microdialysis probe was placed in all patients, who were managed according to standard protocols for the treatment of severe head injury. Findings The most robust result of this study was that, over most of the monitoring period, brain dialysate glucose was significantly higher in the CsA treated patients than in placebo. Both lactate and pyruvate were also significantly higher in the CsA group. Glutamate concentration and lactate/pyruvate ratio were significantly higher in the placebo group than in CsA treated patients, respectively 1 to 2?days, and 2 to 3?days after the end of the 24-h drug infusion. The administration of CsA was also associated with a significant increase in mean arterial pressure (MAP) and cerebral perfusion pressure (CPP). Conclusions The administration of CsA in the early phase after head injury resulted in significantly higher extracellular fluid glucose and pyruvate, which may be evidence of a beneficial effect. The early administration of CsA was also associated with a significant increase in MAP and CPP and such a potentially beneficial hemodynamic effect might contribute to a neuroprotective effect.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700